Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-03

Clinical Trial Update: Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study compares the bioavailability of Omexa Sumatriptan versus Imitrex in healthy volunteers for migraine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imitrex (Sumatriptan)
  • Omexa Sumatriptan (Sumatriptan)

Snippet

Sponsor: Targia Pharmaceuticals Ltd. | Conditions: Migraine | Phase 1 | Status: UNKNOWN